Evolution of Antithrombotic Management of Atrial Fibrillation After Percutaneous Coronary Intervention Over 10 Years and Guidelines Uptake

Evolution of Antithrombotic Management of Atrial Fibrillation After Percutaneous Coronary Intervention Over 10 Years and Guidelines Uptake

Background: The management of atrial fibrillation and/or flutter (AF) patients requiring percutaneous coronary intervention (PCI) has evolved significantly. The Canadian Cardiovascular Society AF guidelines, last updated in 2020, seek to aid physicians in balancing both bleeding and thrombotic risks...

Full description

Bibliographic Details
Main Authors: Marie-Claude Beaulieu, MD, Laurie-Anne Boivin-Proulx, MD, Alexis Matteau, MD, SM, Samer Mansour, MD, Jean-François Gobeil, MD, Brian J. Potter, MDCM, SM
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:CJC Open
Online Access:http://www.sciencedirect.com/science/article/pii/S2589790X21000974

Internet

http://www.sciencedirect.com/science/article/pii/S2589790X21000974

Similar Items